Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs.
Manel Mata-CasesJ MahonD MauricioJ Franch-NadalJ RealN HexPublished in: BMC health services research (2020)
Over a 25 year period, Spain could considerably reduce costs and avoid major complications if, on a population level, more ambitious glycaemic control, according to Spanish or EU guidelines, could be achieved among people with type 2 diabetes by reducing the HbA1c threshold for treatment intensification. Although there is a slower trajectory for benefits in earlier years, there is a much more rapid benefit gain between years 5 and 15.